Abstract
Carbapenem-resistant nosocomial K. pneumoniae isolates are a significant problem in clinical practice. Carbapenem resistance in K. pneumoniae isolated from hospitalized patients was 2.8% over the study period. NDM-1 carbapenemase-producing strains were the most prevalent ones. K. pneumoniae strains with OXA-48 were isolated more rarely, and KPC-2 was determined in 2 cases. NDM-1 gene was detected in multiple K. pneumoniae sequence types (ST340, ST147, ST11, ST307). OXA-48 gene was determined in K. pneumoniae ST395 and KPC-2 gene was determined in K. pneumoniae ST15 and ST258.
Federal Almazov North-West Medical Research Center, Saint-Petersburg, Russia
Federal Almazov North-West Medical Research Center, Saint-Petersburg, Russia
Federal Almazov North-West Medical Research Center, Saint-Petersburg, Russia
-
1.
Yamamoto M., Pop-Vicas A.E. Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have? Critical Care 2014; 18:229.
-
2.
Monaco M., Giani T., Raffone M., et al. Colistin resistance superimposed to endemic carbapenemresistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014; 19(42):14-8.
-
3.
Poirel L., Bonnin R. A., Nordmann P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother 2012; 56(1):559-62.
-
4.
Пестова Н.Е., Баранцевич Н.Е., Рыбкова Н.С., Козлова Н.С., Баранцевич Е.П. Изучение эффективности применения метода секвенирования ДНК по фрагменту гена 16s рРНК для идентификации микроорганизмов. Профилактическая и клиническая медицина 2011; 4:57-8.
-
5.
Barantsevich E.P., Churkina I.V., Barantsevich N.E., Pelkonen J., Schlyakhto E.V., Woodford N. Emergence of Klebsiella pneumoniae producing NDM-1 carbapenemase in Saint Petersburg, Russia. J Antimicrob Chemother 2013; 68(5):1204-
-
6.
Diancourt L., Passet V., Verhoef J., Grimont P.A., Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43(8):4178- 82.
-
7.
Falagas M.E., Lourida P., Poulikakos P., Rafailidis P.I., Tansarli G.S. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother 2014; 58(2):654-63.
-
8.
Borges C.A., de Cássia de Andrade M.R., Vieira M.A., Souza L.A. C. Multidrug resistance genes, including blaKPC and blaCTX–M-2, among Klebsiella pneumoniae isolated in Recife, Brazil. Rev Soc Bras Med Trop 2012; 45(5):572-8.
-
9.
Nordmann P., Naas T., Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17:1791-8.
-
10.
Giske C.G., Fröding I., Hasan C.M., et al. Diverse Sequence Types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom. Antimicrob Agents Chemother 2012; 56(5):2735-8.
-
11.
Arnold R. S., Thom K. A., Sharma S., Phillips M., Johnson J.K., Morgan D.J. Emergence of Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria. South Med J 2011; 104(1):40-5.
-
12.
Al-Qadheeb N.S., Althawadi S., Alkhalaf A., Hosaini S., Alrajhi A.A. Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient. Ann Saudi Med 2010; 30(5): 404-7.